Compare PCG & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCG | MDLN |
|---|---|---|
| Founded | 1995 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0B | 31.0B |
| IPO Year | 2000 | 2025 |
| Metric | PCG | MDLN |
|---|---|---|
| Price | $14.15 | $36.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 23 |
| Target Price | $22.19 | ★ $50.48 |
| AVG Volume (30 Days) | ★ 42.8M | 6.7M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | ★ 2.61 | N/A |
| EPS | ★ 0.72 | 0.23 |
| Revenue | $24,935,000,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $7.24 | $10.88 |
| Revenue Next Year | $3.41 | $7.69 |
| P/E Ratio | ★ $19.45 | $160.26 |
| Revenue Growth | 2.11 | ★ 11.47 |
| 52 Week Low | $12.59 | $32.49 |
| 52 Week High | $19.16 | $50.88 |
| Indicator | PCG | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 33.05 | 54.11 |
| Support Level | N/A | $35.07 |
| Resistance Level | $16.82 | $37.79 |
| Average True Range (ATR) | 0.80 | 1.23 |
| MACD | -0.50 | 0.37 |
| Stochastic Oscillator | 24.33 | 98.54 |
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.